Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Better evidence needed to define, treat PCOS Regina Schaffer
-
- ‘Another agent in our arsenal’: Finerenone benefits extend to those with, without CVD Regina Schaffer
- Black, Hispanic adults receive unequal treatment for adrenalectomy Regina Schaffer
- COVID-19 pandemic shows CGM ‘supportive tool’ for broad inpatient use Regina Schaffer
- Endocrinology Drug and Device Update
- Hyperglycemia in type 1 diabetes more prevalent among women with disordered eating Michael Monostra
- Levothyroxine overtreatment during pregnancy increases odds for preterm delivery Michael Monostra
- Managing dyslipidemia in pregnant women challenging Erik Swain
- Many drug therapy options exist for NAFLD Erik Swain
-
- New E/M codes poised to increase endocrine reimbursement, reduce paperwork Jonathan D. Leffert, MD, FACP, FACE, ECNU
- No association between hypothyroidism, poor COVID-19 outcomes Michael Monostra
- Report calls for global action to reduce EDC exposure from plastics Michael Monostra
- SCORED/SOLOIST: Dual SGLT inhibitor shows new CV benefits in type 2 diabetes Regina Schaffer
- Transgender women outpace cisgender women in athletic tests after 1 year on hormones Michael Monostra
- Type 2 diabetes alters bone composition after menopause Michael Monostra
- CGM reveals nighttime hyperglycemia in gestational diabetes Michael Monostra
- Risk for type 2 diabetes remains more than 2 decades after gestational diabetes Michael Monostra
-
- RNA sequencing fails to detect many genetic variants in thyroid tumor, tissue samples Michael Monostra
- Should expert opinion be included in PCOS guidelines when evidence is limited?